ArticleExperimental hematology & oncology2026
Optimizing the timing of JAK1 inhibition preserves the anti-tumor efficacy of radioimmunotherapy in lung cancer by preventing T cell exhaustion.
Zhiru Gao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.